LATS2 and neoplasm: As a key serine/threonine kinase in the Hippo signaling pathway, LATS2 phosphorylates the Hippo downstream effector YAP oncoprotein, reduces the level of YAP, and inhibits its shuttling from the cytoplasm to the nucleus, to exert its tumor-suppressive effects [27].